HerzPub Date : 2024-10-01Epub Date: 2024-08-30DOI: 10.1007/s00059-024-05265-y
Simon Glück, Christian Perings
{"title":"[eHealth: digital bridges in the healthcare system].","authors":"Simon Glück, Christian Perings","doi":"10.1007/s00059-024-05265-y","DOIUrl":"10.1007/s00059-024-05265-y","url":null,"abstract":"<p><p>Healthcare in Germany is divided into various service sectors, which differ in terms of outpatient and inpatient care as well as the legal and financial bases. The resulting breaks in consecutive patient care are to be overcome by integrating services into cross-sectoral processes (integrated care). Digitalization and the associated use of information and communication technology (ICT) play a decisive role in this. To derive implications and benefits it is necessary to classify the technical possibilities. For this purpose, eHealth is the basic generic term for all process support and direct patient applications that are based on the electronic exchange of data. A distinction can be made between technology for process support and technology for direct application on the patient. Applications in all categories are suitable for ensuring that interfaces in the flow of information between those involved in healthcare processes are adequately managed by eHealth. Furthermore, the allocation of specialized medicine through eHealth is independent of location and sector. New possibilities for generating and using structured data for evidence development and care research are realized through eHealth and the development of existing and new care models will be promoted.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"335-341"},"PeriodicalIF":1.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142106744","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-10-01Epub Date: 2024-08-30DOI: 10.1007/s00059-024-05263-0
A A Derda, A Hohneck
{"title":"[Lifelong learning in cardiology: success through innovation : Use of e-learning in further education and training].","authors":"A A Derda, A Hohneck","doi":"10.1007/s00059-024-05263-0","DOIUrl":"10.1007/s00059-024-05263-0","url":null,"abstract":"<p><p>Lifelong learning in cardiology is essential, as treatment standards, technologies and drug treatment are constantly evolving. In this respect e‑learning plays a central role, enabling doctors to flexibly and efficiently expand their knowledge. There are various offerings, from medical students and specialist training to highly specialised expert knowledge. The e‑learning platforms have become an indispensable tool in specialist training. Another concept is the combination of face-to-face teaching and e‑learning, known as blended learning. This is particularly effective in medical training. These models enable flexible preparation and follow-up and appeal to different types of learners. Overall, e‑learning offers a valuable resource for flexibly and efficiently acquiring knowledge and keeping up to date.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"321-326"},"PeriodicalIF":1.1,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142106745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-09-24DOI: 10.1007/s00059-024-05272-z
Chengye Di, Haijiang Wang, Mingming Wang, Qun Wang, Yanxi Wu, Longyu Li, Yan Zhang, Wenhua Lin
{"title":"Acute atrial infarction: a relatively neglected and under-recognized entity in clinical practice.","authors":"Chengye Di, Haijiang Wang, Mingming Wang, Qun Wang, Yanxi Wu, Longyu Li, Yan Zhang, Wenhua Lin","doi":"10.1007/s00059-024-05272-z","DOIUrl":"https://doi.org/10.1007/s00059-024-05272-z","url":null,"abstract":"<p><strong>Background: </strong>Electrocardiograms (ECGs) and angiographic features indicative of acute atrial infarction (AAI) often go unnoticed and are under-recognized in clinical practice.</p><p><strong>Methods: </strong>In this retrospective observational study, we analyzed the data of 3981 out of 9803 patients (40.61%) who were referred to our hospital for angiography and/or percutaneous coronary intervention due to acute coronary syndrome (ACS). These patients were diagnosed with acute ST segment elevation myocardial infarction (AMI) affecting the inferior, posterior, and/or right ventricular regions.</p><p><strong>Results: </strong>Of the 3981 patients, 270 (6.78%) had involvement of the main coronary atrial branch meeting the angiographic criteria for AAI. Among the 270 patients identified, the right coronary artery was diagnosed as the infarct-related artery (IRA) in 187 patients (group R), while the left circumflex artery was the IRA in 83 patients (group L). The incidence of PR-segment deviation was similar between the two groups (65.2% in group R vs. 66.3% in group L, p = 0.870), as was occurrence of atrial tachyarrhythmia (67.4% vs. 55.4%, p = 0.059). The prevalence of P wave morphology abnormalities (29.9% vs. 49.4%, p = 0.005) and sinus bradycardia or arrest (25.1% vs. 66.3%, p < 0.001) was significantly lower in Group R than in Group L.</p><p><strong>Conclusion: </strong>Acute atrial infarction represents a distinct yet frequently overlooked clinical entity. Clinicians should consider the potential for atrial arrhythmias, thromboembolism, hemodynamic instability, and atrial rupture when diagnosing AAI.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-09-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142307541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-09-23DOI: 10.1007/s00059-024-05275-w
Fernando Baía Bezerra, Luis Eduardo Rodrigues Sobreira, Vitor Kendi Tsuchiya Sano, Artur de Oliveira Macena Lôbo, Jorge Henrique Cavalcanti Orestes Cardoso, Francinny Alves Kelly, Francisco Cezar Aquino de Moraes, Fernanda Marciano Consolim-Colombo
{"title":"Efficacy of sacubitril-valsartan vs. angiotensin-converting enzyme inhibitors or angiotensin receptor blockers in preventing atrial fibrillation recurrence after catheter ablation: a systematic review and meta-analysis.","authors":"Fernando Baía Bezerra, Luis Eduardo Rodrigues Sobreira, Vitor Kendi Tsuchiya Sano, Artur de Oliveira Macena Lôbo, Jorge Henrique Cavalcanti Orestes Cardoso, Francinny Alves Kelly, Francisco Cezar Aquino de Moraes, Fernanda Marciano Consolim-Colombo","doi":"10.1007/s00059-024-05275-w","DOIUrl":"10.1007/s00059-024-05275-w","url":null,"abstract":"<p><strong>Background: </strong>Patients who have undergone catheter ablation for atrial fibrillation (AF) may experience recurrence of this condition. The efficacy of sacubitril-valsartan (S/V) in preventing AF recurrence compared with angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II receptor blockers (ARBs) is not established. This meta-analysis aimed to establish the best therapeutic choice for preventing AF recurrence after catheter ablation.</p><p><strong>Method: </strong>A systematic search of the PubMed, Embase, and Cochrane databases was conducted for randomized controlled trials (RCTs) and observational studies comparing the use of S/V with ACEI/ARB in patients who underwent catheter ablation. Results are presented as mean difference (MD) with 95% confidence interval (CI). Heterogeneity was assessed with the I<sup>2</sup> statistic, and outcomes are expressed as relative risk (RR). R software version 4.2.3 was used for the analysis.</p><p><strong>Results: </strong>Three RCTs and one cohort study, comprising 642 patients with 319 patients in the S/V group and 323 in the control group, were included. Follow-up ranged from 6 to 36 months, with mean ages ranging from 58.9 to 65.8 years. A significant reduction in persistent AF occurrence was demonstrated favoring the S/V group (RR: 0.54; 95% CI: [0.41, 0.70]; p = 0.000004; I<sup>2</sup>: 80%) over the ACEI/ARB group. There was no significant difference in left ventricular ejection fraction with S/V use (MD: 1.23; 95% CI: [-0.12, 2.60]; p = 0.076; I<sup>2</sup>: 0%) compared with ACEI/ARB. The analysis also showed a significant reduction in left atrial volume index (MD: -5.33; 95% CI: [-8.76, -1.90]; p = 0.002; I<sup>2</sup>: 57%) in the S/V group compared with the ACEI/ARB group.</p><p><strong>Conclusion: </strong>This meta-analysis demonstrated the efficacy of S/V in reducing the incidence of AF in patients undergoing catheter ablation compared with the use of ACEI/ARB. However, more RCTs are needed for a comprehensive evaluation of its efficacy in reducing AF recurrence after catheter ablation in clinical practice.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":""},"PeriodicalIF":1.1,"publicationDate":"2024-09-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142307522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-09-10DOI: 10.1007/s00059-024-05269-8
Omar Hahad, Jos Lelieveld, Sadeer Al-Kindi, Volker H. Schmitt, Lukas Hobohm, Karsten Keller, Martin Röösli, Marin Kuntic, Andreas Daiber
{"title":"Burden of disease in Germany attributed to ambient particulate matter pollution","authors":"Omar Hahad, Jos Lelieveld, Sadeer Al-Kindi, Volker H. Schmitt, Lukas Hobohm, Karsten Keller, Martin Röösli, Marin Kuntic, Andreas Daiber","doi":"10.1007/s00059-024-05269-8","DOIUrl":"https://doi.org/10.1007/s00059-024-05269-8","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Introduction</h3><p>Ambient fine particulate matter pollution with a diameter less than 2.5 micrometers (PM<sub>2.5</sub>) is a significant risk factor for chronic noncommunicable diseases (NCDs), leading to a substantial disease burden, decreased quality of life, and deaths globally. This study aimed to investigate the disease and mortality burdens attributed to PM<sub>2.5</sub> in Germany in 2019.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>Data from the Global Burden of Disease (GBD) Study 2019 were used to investigate disability-adjusted life–years (DALYs), years of life lost (YLLs), years lived with disability (YLDs), and deaths attributed to ambient PM<sub>2.5</sub> pollution in Germany.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>In 2019, ambient PM<sub>2.5</sub> pollution in Germany was associated with significant health impacts, contributing to 27,040 deaths (2.82% of total deaths), 568,784 DALYs (2.09% of total DALYs), 135,725 YLDs (1.09% of total YLDs), and 433,058 YLLs (2.92% of total YLLs). The analysis further revealed that cardiometabolic and respiratory conditions, such as ischemic heart disease, stroke, chronic obstructive pulmonary disease, lung cancer, and diabetes mellitus, were the leading causes of mortality and disease burden associated with ambient PM<sub>2.5</sub> pollution in Germany from 1990–2019. Comparative assessments between 1990 and 2019 underscored ambient PM<sub>2.5</sub> as a consistent prominent risk factor, ranking closely with traditional factors like smoking, arterial hypertension, and alcohol use contributing to deaths, DALYs, YLDs, and YLLs.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>Ambient PM<sub>2.5</sub> pollution is one of the major health risk factors contributing significantly to the burden of disease and mortality in Germany, emphasizing the urgent need for targeted interventions to address its substantial contribution to chronic NCDs.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":"9 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142224665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-09-10DOI: 10.1007/s00059-024-05268-9
Ocílio Ribeiro Gonçalves, Francinny Alves Kelly, José Guilherme Maia, Artur de Oliveira Macena Lôbo, Vitor Kendi Tsuchiya Sano, Maria Eduarda Cavalcanti Souza, Francisco Cezar Aquino de Moraes, Nimra Farid, Arlindo Bispo da Silva Júnior, Avelar Alves da Silva
{"title":"Assessing the efficacy of renal denervation in patients with resistant arterial hypertension","authors":"Ocílio Ribeiro Gonçalves, Francinny Alves Kelly, José Guilherme Maia, Artur de Oliveira Macena Lôbo, Vitor Kendi Tsuchiya Sano, Maria Eduarda Cavalcanti Souza, Francisco Cezar Aquino de Moraes, Nimra Farid, Arlindo Bispo da Silva Júnior, Avelar Alves da Silva","doi":"10.1007/s00059-024-05268-9","DOIUrl":"https://doi.org/10.1007/s00059-024-05268-9","url":null,"abstract":"<h3 data-test=\"abstract-sub-heading\">Background</h3><p>Renal denervation (RDN) is an innovative procedure designed to regulate the renal sympathetic nervous system for the control of arterial hypertension (HTN). RDN has emerged as an alternative for patients with resistant HTN. However, the clinical efficacy of RDN remains incompletely elucidated.</p><h3 data-test=\"abstract-sub-heading\">Methods</h3><p>PubMed, Embase, and Cochrane databases were searched for randomized controlled trials (RCTs) comparing the use of RDN with sham procedure or pharmacological treatment in patients with resistant HTN. Statistical analyses were performed using R Studio 4.3.2 (R Foundation for Statistical Computing, Vienna, Austria). Heterogeneity was examined with the Cochran Q test I<sup>2</sup> statistics. Mean difference (MD) with 95% confidence interval (CI) were pooled across trials. <i>P</i> values of <0.05 were considered statistically significant. The primary outcomes of interest were changes from baseline in systolic blood pressure (SBP), diastolic blood pressure (DBP), and serum creatinine.</p><h3 data-test=\"abstract-sub-heading\">Results</h3><p>Twenty-one RCTs comprising 3345 patients were included in this meta-analysis, whereby 2004 (59.91%) received renal denervation and 1341 (40.09%) received pharmacological treatment or sham procedure. Follow-up ranged from 2 to 48 months. Compared to control group, RDN significantly reduced SBP (MD −3.53 mm Hg; 95% CI −5.94 to −1.12; <i>p</i> = 0.004; I<sup>2</sup> = 74%) and DBP (MD −1.48 mm Hg; 95% CI −2.56 to −0.40; <i>p</i> = 0.007; I<sup>2</sup> = 51%). Regarding serum creatinine (MD −2.51; 95% CI −7.90 to 2.87; <i>p</i> = 0.36; I<sup>2</sup> = 40%), there was no significant difference between RDN and control groups.</p><h3 data-test=\"abstract-sub-heading\">Conclusion</h3><p>In this meta-analysis of RCTs of patients with resistant HTN, RDN was associated with a reduction in SBP and DBP compared to sham procedure or pharmacological treatment.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":"20 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142186980","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-09-02DOI: 10.1007/s00059-024-05262-1
S. Manteufel, D. Duncker
{"title":"Rechtliche Aspekte in der digitalen Kardiologie","authors":"S. Manteufel, D. Duncker","doi":"10.1007/s00059-024-05262-1","DOIUrl":"https://doi.org/10.1007/s00059-024-05262-1","url":null,"abstract":"<p>Digitale Helfer sind inzwischen ein unverzichtbares Werkzeug in der modernen Kardiologie. Der damit einhergehende technologische Fortschritt bietet hierbei ein ausgesprochenes Potenzial, die Effizienz medizinischer Prozesse zu steigern, in kürzester Zeit präzisere Diagnosen zu ermöglichen und damit die Patientenversorgung zu verbessern. Doch mit der zunehmenden Integration digitaler Helfer im sonst arbeitsintensiven kardiologischen Berufsalltag ergeben sich auch neue Herausforderungen und Fragestellungen, insbesondere im Hinblick auf den Umgang mit dem Thema Recht. Der vorliegende Übersichtsartikel zielt darauf ab, ein Bewusstsein für einzelne juristische Themen zu schaffen, die aus der Verwendung digitaler Technologien in der Kardiologie resultieren. Dabei wird es im Kern um den wohlüberlegten Umgang mit den haftungsrechtlichen Themen der Therapiefreiheit, des kardiologischen Facharztstandards, der ärztlichen Schweigepflicht wie auch des Datenschutzes gehen. Die Integration digitaler Helfer in der Kardiologie führt insgesamt zu einer spürbaren Verbesserung der Effizienz und Qualität der Patientenversorgung, beinhaltet jedoch gleichzeitig eine Vielzahl rechtlicher Herausforderungen, die sorgfältig adressiert werden müssen.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":"40 1","pages":""},"PeriodicalIF":1.7,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142224666","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Is an accurate self-perceived health risk beneficial for patients to minimize prehospital delay time at onset of a ST-segment elevated myocardial infarction (STEMI)?","authors":"Karl-Heinz Ladwig, Elisabeth Olliges, Loai Albarqouni, Sophia Hoschar, Wenlin Ma, Xiaoyan Fang","doi":"10.1007/s00059-024-05256-z","DOIUrl":"10.1007/s00059-024-05256-z","url":null,"abstract":"<p><p>High risk perception (HRP) is fundamental for adequate health behavior. However, its impact on rapid access to cardiac care after the onset of acute myocardial infarction (AMI) is not known. Conflicting evidence exists about sources that promote HRP. Data on sociodemographic and clinical characteristics of 588 AMI patients who participated in the Munich Examination of Delay in Patients Experiencing Acute Myocardial Infarction (MEDEA) study were collected at the bedside. Adjusted multivariate logistic regression models identified factors associated with HRP. Only 13.4% (n = 79) of patients had a favorable HRP level. The HRP patients did not differ from those with low risk perception (LRP) in terms of sex, age, other sociodemographic features, and somatic risk factors. Among the univariate contributors to HRP were prodromal chest pain (p = 0.0004), symptom mismatch during AMI (p < 0.0001), depression (p = 0.01), and anxiety (p = 0.005). However, family history of AMI, a previous AMI, and knowledge of AMI remained significant in the multivariate regression model. Median delay time to reach a hospital-based emergency facility after the onset of AMI was 127 min (interquartile range [IQR]: 83-43, p = 0.02) in HRP patients and 216 min (IQR: 106-721) in LRP patients. An increasing risk perception score was associated with a corresponding stepwise decline in median delay time (p > 0.004). Self-perceived AMI risk is associated in a dose-response relationship with the time needed to reach coronary care emergency facilities. Recurrent AMI, family history of AMI, and sufficient knowledge of MI contribute to risk perception, whereas somatic risk factors do not.</p>","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"270-276"},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141534315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
HerzPub Date : 2024-08-01Epub Date: 2023-11-20DOI: 10.1007/s00059-023-05223-0
Omar Hahad
{"title":"Environmental and climate cardiology: some environmental issues highlighted at the annual meetings of the German Society for Cardiology (DGK) from 2007 to 2023.","authors":"Omar Hahad","doi":"10.1007/s00059-023-05223-0","DOIUrl":"10.1007/s00059-023-05223-0","url":null,"abstract":"","PeriodicalId":12863,"journal":{"name":"Herz","volume":" ","pages":"309-312"},"PeriodicalIF":1.1,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11286620/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138176001","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}